Insurers eye contingent capital as solution to Solvency II volatility

Uncertain path

uncertain path

This year, interest in contingent convertible instruments (CoCos) has been limited. Despite some encouraging banking deals earlier in the year, a lack of regulatory clarity has left potential issuers hesitant. However, a recent issuance of the instruments by Munich-based insurer Allianz suggests that a market for insurer-issued CoCos could be on the horizon.

Prior to the Allianz deal, these loss-absorbing regulatory capital instruments, which could either be written down or converted to equity

To continue reading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: